Friday, May 14, 2021

Rockwell Medical, Inc. (RMTI) Prices Soar Ahead of Data Presentation at Conference

Rockwell Medical, Inc. (RMTI) stock prices were up by a massive 15.48% shortly after the trading day commenced on April 23rd, 2021, bringing the price per share up to a comfortable USD$1.08.


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



2020 Revenues for RMTI

RMTI reported Q4 2020 revenues of USD$ 15.2 million, as compared to USD$15.5 million for the same time period of the previous year. Annual revenues for the year ended December 31st, 2020 were up to USD$62.2 million, up from USD$61.3 million for the year ended December 21st, 2019.

Triferic Sales


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


Commercial sales of Triferic contributed USD$0.5 million to the fourth quarter revenue reports and USD$1.1 million for the year ended December 31st, 2020. The sample evaluation program in Q2 2019 signaled the launch of Triferic, which was reported by New York University to result in cost savings of USD$296,000. Revenue generated from Triferic came out to USD$1.1 million in 2020, with its IV formulation being made commercially available to patients across the United States.

Global Proliferation of Triferic

September saw RMTI collaborate with Jeil Pharma Co. Ltd. In obtaining exclusive rights for the drug. Jeil filed a New Drug Application for two variants of Triferic in February of 2021. January 2021 saw the enrolment of the first patient in a pivotal Phase trial conducted by Wanbang Biopharmaceuticals. January of the previous year had seen RMTI enter into a licensing agreement with Sun Pharma, which is undergoing the regulatory process in India. Furthermore, RMTI announced that in May of 2020 it was filing a New Drug Submission with Health Canada.

Other Developments

The U.S. Food and Drug Administration accepted RMTI’s proposed development strategy, with a successful outcome allowing for the initiation of a clinical study during the second half of 2021.RMTI is also exploring how its FPC platform could be used in the treatment of acute heart failure patients who are hospitalized.

Strong Financial Reports

The company reported USD$58.7 million as of December 31st, 2020 in cash, cash equivalents, and investments available-for-sale. Working capital as of the same date was reported at USD$56.7 million. With a debt facility of USD$35 million that released the first portion of USD$22.5 million in March of 2020, RMTI classifies this as long-term debt on the balance sheet. Pending the reaching of specific milestones largely centered around Triferic sales thresholds, RMTI could be eligible for the third tranche of USD$7.5 million.

Future Outlook for RMTI

With promising financials, large reserves of cash, and such promising developments in the proliferation of Triferic, RMTI is poised for a successful 2021. Investors are hopeful for large gains in shareholder value, as evidenced by the significant driving up of RMTI stock prices.

Latest news

What is behind the fall of Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock?

Torchlight Energy Resources, Inc. (NASDAQ: TRCH), a growth oil and gas exploration company specializing in the acquisition and development of highly profitable domestic oil...

Eros STX Global Corporation (ESGC) stock is declining: Here is the reason why?

Eros STX Global Corporation (NYSE ESGC) a global multinational media company that acquires, produces, and distributes films, television shows, and digital content issued its...

Yum China Holdings Inc. (YUMC): The Most Important Numbers You Should Know

Yum China Holdings Inc. (YUMC), which operates Taco Bell Restaurants, KFC Restaurants, and Pizza Hut Restaurants in China, has published its first-quarter report for...

Why shares of Akerna Corp. (KERN) stock are up today?

Akerna (KERN), a cannabis technology company focusing to connect data points in the global cannabis supply chain and developer of the cannabis industry's first...

Related news

What is behind the fall of Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock?

Torchlight Energy Resources, Inc. (NASDAQ: TRCH), a growth oil and gas exploration company specializing in the acquisition and development of highly profitable domestic oil...

Eros STX Global Corporation (ESGC) stock is declining: Here is the reason why?

Eros STX Global Corporation (NYSE ESGC) a global multinational media company that acquires, produces, and distributes films, television shows, and digital content issued its...

Yum China Holdings Inc. (YUMC): The Most Important Numbers You Should Know

Yum China Holdings Inc. (YUMC), which operates Taco Bell Restaurants, KFC Restaurants, and Pizza Hut Restaurants in China, has published its first-quarter report for...

Why shares of Akerna Corp. (KERN) stock are up today?

Akerna (KERN), a cannabis technology company focusing to connect data points in the global cannabis supply chain and developer of the cannabis industry's first...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.